Skip to content
CapRadio

CapRadio

signal status listen live donate
listen live donate signal status
listen live donate signal status
  • News
    • topics
    • State Government
    • Environment
    • Health Care
    • Race and Equity
    • Business
    • Arts and Lifestyle
    • Food and Sustainability
    • PolitiFact California
  • Music
    • genres
    • Classical
    • Jazz
    • Eclectic
    • Daily Playlist
  • Programs + Podcasts
    • news
    • Morning Edition
    • All Things Considered
    • Marketplace
    • Insight With Vicki Gonzalez
    • music
    • Acid Jazz
    • At the Opera
    • Classical Music
    • Connections
    • Excellence in Jazz
    • Hey, Listen!
    • K-ZAP on CapRadio
    • Mick Martin's Blues Party
    • Programs A-Z
    • Podcast Directory
  • Schedules
    • News
    • Music
    • ClassicalStream
    • JazzStream
    • Weekly Schedule
    • Daily Playlist
  • Community
    • Events Calendar
    • CapRadio Garden
    • CapRadio Reads
    • Ticket Giveaways
  • Support
    • Evergreen Gift
    • One-Time Gift
    • Corporate Support
    • Vehicle Donation
    • Stock Gift
    • Legacy Gift
    • Endowment Gift
    • Benefits
    • Member FAQ
    • e‑Newsletter
    • Drawing Winners
    • Thank You Gifts
  • About Us
  • Contact Us
  • Close Menu
 We Get Support From:
Become a Supporter 
 We Get Support From:
Become a Supporter 
  • Health Care
  •  

UC Davis Chemists Tested 'Microdoses' Of Psychedelic Drugs On Rats (And It Kind of Worked)

  •  Sammy Caiola 
Thursday, March 7, 2019 | Sacramento, CA
Courtesy of UC Regents

David Olson (lef) with the UC Davis Department of Chemistry works in the lab last year with Alaysia Madison. Olson is currently studying the effects of small doses of psychedelic drugs on rats.

Courtesy of UC Regents

A team of chemists at UC Davis wanted to know if tiny doses of psychedelic drugs — also called microdoses — could have benefits for rats, without making them hallucinate.

The answer is yes, according to research published Monday.

“If we really don’t need the hallucinogenic effects to produce therapeutic effects, then that might suggest that psychedelics could be used kind of as lead structures to develop safer alternatives,” said lead researcher David Olson.

Olson and his team gave rats DMT — a compound that’s structurally similar to LSD — every few days for two months. But they only administered a tenth of a hallucinogenic dose. It’s called “microdosing,” and some humans do it to reduce anxiety or improve focus. It hasn’t been proven safe or effective.

After two weeks, tests on the rats showed the drug was reducing fear and having similar effects to antidepressants, but did little to improve sociability or cognitive function. There were some adverse effects, including a loss of brain cells in females.

Olson says it’s possible to develop a drug that’s properly dosed to have positive impacts without psychedelic effects. But there would be a high risk for abuse, and possibly other issues.

“Using these ahead of time on a regular dosing schedule potentially could be interesting as a preventive measure,” he said. “There’s a lot more research that needs to be done in that area though.”

And he says people who choose to microdose themselves are taking a risk.

“They could be harming themselves,” he says. “Because again, we just don’t know."

This story has been updated to clarify the potential risks of creating prescription psychedelics.


Follow us for more stories like this

CapRadio provides a trusted source of news because of you.  As a nonprofit organization, donations from people like you sustain the journalism that allows us to discover stories that are important to our audience. If you believe in what we do and support our mission, please donate today.

Donate Today  

Andrew Nixon / CapRadio

Sammy Caiola

Former Healthcare Reporter

Sammy Caiola has been covering medical breakthroughs, fitness fads and health policy in California since 2014. Before joining CapRadio, Sammy was a health reporter at The Sacramento Bee.  Read Full Bio 

 @sammycaiola Email Sammy Caiola

Coronavirus Newsletter

Get answers to your questions, the latest updates and easy access to the resources you need, delivered to your inbox.

 

Want to know what to expect? Here's a recent newsletter.

Thanks for subscribing!

We'll send you weekly emails so you can stay informed about the coronavirus in California.

Browse all newsletters

More Health Care Stories

Scott Olson/Getty Images

FDA authorizes first COVID booster for children ages 5 to 11

May 17, 2022

AP Photo/Rich Pedroncelli, File

Sacramento-area schools seeing rise in COVID-19 cases, but don’t plan to require masks again

May 17, 2022

Justin Sullivan / Getty Images

The federal government is offering another round of free COVID tests

May 16, 2022

Most Viewed

Top California Democrats in a stalemate over gas rebates

Downtown Sacramento shooting: What we know and latest updates

U.S. Sen. Alex Padilla will appear on California’s June primary ballot twice. Here’s why.

With California budget surplus projected at $97 billion, Newsom proposes driver rebates, more reproductive health funding

California coronavirus updates: Nevada ends COVID-19 emergency declarations

We Get Support From:
Become a Supporter

Most Viewed

Top California Democrats in a stalemate over gas rebates

Downtown Sacramento shooting: What we know and latest updates

U.S. Sen. Alex Padilla will appear on California’s June primary ballot twice. Here’s why.

With California budget surplus projected at $97 billion, Newsom proposes driver rebates, more reproductive health funding

California coronavirus updates: Nevada ends COVID-19 emergency declarations

Back to Top

  • CapRadio

    7055 Folsom Boulevard
    Sacramento, CA 95826-2625

    • (916) 278-8900
    • Toll-free (877) 480-5900
    • Email Us
    • Submit a News Tip
  • Contact Us

  • About Us

    • Contact Us / Feedback
    • Coverage
    • Directions
    • Careers & Internships
    • Mission / Vision / Core Values
    • Press
    • Staff Directory
    • Board of Directors
  • Listening Options

    • Mobile App
    • On Air Schedules
    • Smart Speakers
    • Playlist
    • Podcasts
    • RSS
  • Connect With Us

    •  Facebook
    •  Twitter
    •  Instagram
    •  YouTube
  • Donate

  • Listen

  • Newsletters

CapRadio stations are licensed to California State University, Sacramento. © 2022, Capital Public Radio. All Rights Reserved. Privacy Policy | Website Feedback FCC Public Files: KXJZ KKTO KUOP KQNC KXPR KXSR KXJS. For assistance accessing our public files, please call 916-278-8900 or email us.